{"id":"gemtesa","rwe":[],"tags":[],"trials":[],"_chembl":null,"aliases":[],"patents":[],"pricing":[{"market":"United States","source":"CMS National Average Drug Acquisition Cost (NADAC)","asOfDate":"2024-01-03","unitCost":"$15.0670/EA","priceType":"NADAC","sourceUrl":"https://data.medicaid.gov/dataset/4j6z-xnwq","annualCost":"$5,499","description":"GEMTESA 75 MG TABLET","retrievedDate":"2026-04-07"}],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=Gemtesa","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T00:56:27.893874+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T00:56:34.232442+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=Gemtesa","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T00:56:34.872806+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Beta-3 adrenergic receptor agonist","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:56:35.424948+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2107826/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:56:35.325842+00:00"}},"offLabel":[],"timeline":[],"_dailymed":{"setId":"25f21d25-14f8-4fda-91f6-7aa8b68aa1c8","title":"GEMTESA (VIBEGRON) TABLET, FILM COATED [SUMITOMO PHARMA AMERICA, INC.\n]"},"ecosystem":[],"_scrapedAt":"2026-03-28T06:06:59.320Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:56:37.184273+00:00","fieldsConflicting":0,"overallConfidence":0.95},"biosimilars":[],"competitors":[],"dataSources":[{"url":"https://data.medicaid.gov/dataset/4j6z-xnwq","name":"CMS National Average Drug Acquisition Cost (NADAC)","fields":["pricing"],"retrievedDate":"2026-04-07"}],"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT06987383","phase":"PHASE3","title":"Vibegron for ENergy Thinking and Resilience in Aging","status":"NOT_YET_RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2026-08","conditions":"Obesity","enrollment":40},{"nctId":"NCT06417177","phase":"EARLY_PHASE1","title":"Impact of Early Aging and Menopause on the Vascular Responses to Hypoxia","status":"RECRUITING","sponsor":"University of Missouri-Columbia","startDate":"2024-06-03","conditions":"Aging, Menopause, Hypoxia","enrollment":75},{"nctId":"NCT05067478","phase":"","title":"Composur: Study to Understand the Performance of Vibegron in Participants with Overactive Bladder (OAB)","status":"COMPLETED","sponsor":"Urovant Sciences GmbH","startDate":"2021-10-28","conditions":"Overactive Bladder","enrollment":403}],"_emaApprovals":[],"_faersSignals":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"chemblId":"CHEMBL2107826"},"formularyStatus":[],"_approvalHistory":[{"date":"20241008","type":"SUPPL","sponsor":"SUMITOMO PHARMA AM","applicationNumber":"NDA213006"},{"date":"20241218","type":"SUPPL","sponsor":"SUMITOMO PHARMA AM","applicationNumber":"NDA213006"},{"date":"20201223","type":"ORIG","sponsor":"SUMITOMO PHARMA AM","applicationNumber":"NDA213006"}],"developmentCodes":[],"ownershipHistory":[],"publicationCount":6,"therapeuticAreas":["Other"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"Gemtesa","genericName":"Gemtesa","companyName":"University of Missouri-Columbia","companyId":"university-of-missouri-columbia","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:56:37.184273+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}